A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Senior)
Sexes Eligible for Study:
Type 2 diabetes diagnosed at least 1 year before inclusion
Blood glucose criteria must be met
Microalbuminuria criteria must be met
Pregnant or nursing females or females of childbearing potential not using a medically approved birth control method
Blood glucose criteria outside the specified range
Microalbuminuria criteria outside the specified range
Serious cardiovascular events within the past 6 months
Other protocol-defined exclusion criteria may apply